119
Participants
Start Date
March 6, 2017
Primary Completion Date
May 2, 2018
Study Completion Date
May 2, 2018
PHP-201 0.25% ophthalmic solution
3 drops daily, 28 days
PHP-201 0.5% ophthalmic solution
3 drops daily, 28 days
Placebo ophthalmic solution
3 drops daily, 28 days
Seoul National University Hospital, Seoul
Lead Sponsor
pH Pharma
INDUSTRY